The effects of insulin and beta-adrenergic stimulation on glucose transport, glut 4 and PKB activation in the myocardium of lean and obese non-insulin dependent diabetes mellitus rats
B. Huisamen et al., The effects of insulin and beta-adrenergic stimulation on glucose transport, glut 4 and PKB activation in the myocardium of lean and obese non-insulin dependent diabetes mellitus rats, MOL C BIOCH, 223(1-2), 2001, pp. 15-25
Glucose uptake, glut 4 translocation and activation of protein kinase B wer
e measured in Langendorff perfused hearts from (i) Wistar control, (ii) lea
n, neonatal Streptozotocin induced (Stz) and (iii) Zucker (fa/fa) obese dia
betic rats of 10-12 weeks old. Hearts were subjected to stimulation with in
sulin, isoproterenol (beta -adrenergic agonist) or a combination of insulin
and isoproterenol, during the perfusion protocol. Basal myocardial glucose
uptake was impaired in both diabetic models, but could be stimulated signi
ficantly by insulin. In the Zucker rats, the time-course of insulin action
was delayed. Insulin and beta -stimulation of glucose uptake were not addit
ive. Evaluation of sarcolemmal membranes from these hearts showed that the
affinity of glut 4 was significantly lower in the Zucker but not in the Stz
hearts while a reduced affinity found with a combination of insulin and be
ta -stimulation in control hearts, was absent in both diabetic models. Tota
l membrane lysates were analyzed for glut 4 expression while an intracellul
ar component was generated to quantify translocation on stimulation as well
as activity of protein kinase B (PKB). At this age, the neonatal Streptozo
tocin induced diabetic animals presented with more faulty regulation concer
ning adrenergic stimulated effects on elements of this signal transduction
pathway while the Zucker fa/fa animals showed larger deviations in insulin
stimulated effects. The overall response of the Zucker myocardium was poore
r than that of the Stz group. No significant modulation of beta -adrenergic
signaling on insulin stimulated glucose uptake was found. The PI-3-kinase
inhibitor wortmannin, could abolish glucose uptake as well as PKB activatio
n elicited by both insulin and isoproterenol.